Last quarter (Q2 2022), BB Biotech's total revenue was $-222.52M, a decrease of -159.06% from the same quarter last year. In Q2, BB Biotech's net income was $-233.06M. See BB Biotech’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ -184.40M	$ -351.23M	$ -396.22M	$ 699.23M	$ 685.24M	$ -465.75M
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Income	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Non Operating Interest Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Other Income Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ -208.53M	$ -357.75M	$ -404.74M	$ 691.25M	$ 677.50M	$ -471.27M
Tax Provision	$ 68.00K	$ 61.00K	$ 67.00K	$ 75.00K	$ 68.00K	$ 71.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -208.59M	$ -357.81M	$ -404.81M	$ 691.17M	$ 677.43M	$ -471.34M
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Basic Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted Average Shares	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income From Continuing And Discontinued Operation	$ -208.59M	$ -357.81M	$ -404.81M	$ 691.17M	$ 677.43M	$ -471.34M
Normalized Income	$ -208.59M	$ -357.81M	$ -404.81M	$ 691.17M	$ 677.43M	$ -471.34M
Interest Expense	$ 904.00K	$ 1.73M	$ 986.00K	$ 883.00K	$ 1.24M	$ 1.09M
EBIT	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBITDA	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―

Currency in USD

BB Biotech Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing